Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,303 total articles

Kestra Medical CEO Executes Pre-Arranged Sale of $312,142 in Stock

Kestra Medical CEO Executes Pre-Arranged Sale of $312,142 in Stock

Brian Daniel Webster, President and Chief Executive Officer at Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), executed a sale of 15,000 common shares on June 15, 2026, totaling $312,142. The transaction, governed by a Rule 10b5-1 trading plan established on September 29, 2025, occurred while the company reported revenue nearly 7% above expectatio…

SoundHound AI COO Michael Zagorsek Sells $484,712 in Stock

SoundHound AI COO Michael Zagorsek Sells $484,712 in Stock

Michael Zagorsek, Chief Operating Officer of SoundHound AI, Inc. (NASDAQ:SOUN), executed a sale of 64,994 Class A Common Stock shares on June 15, 2026, totaling $484,712. The transaction, priced at $7.4578 per share, was structured to cover tax withholding requirements tied to the vesting of restricted stock units granted across multiple years. Pos…

SoundHound AI Executive Transaction and Recent Earnings Overview

SoundHound AI Executive Transaction and Recent Earnings Overview

Majid Emami, Chief Science Officer at SoundHound AI, executed a transaction involving the sale of 28,843 shares on June 15, 2026. The sale was structured to cover tax liabilities associated with the vesting of restricted stock units issued between 2022 and 2025. Following the transaction, Emami retained direct ownership of 472,983 shares, maintaini…

Edwards Lifesciences CEO Zovighian Executes Pre-Arranged Stock Sale

Edwards Lifesciences CEO Zovighian Executes Pre-Arranged Stock Sale

Edwards Lifesciences Corp. (NASDAQ: EW) CEO Bernard J. Zovighian executed a transaction to sell 523 shares of company common stock, totaling $45,982, on June 17, 2026. The sale was conducted indirectly through a trust and adhered to a Rule 10b5-1 trading plan established by Mr. Zovighian on December 12, 2025. This transaction reduces his indirect t…